Robotic transperitoneal aortic lymphadenectomy in gynecologic cancer: A new robotic surgical technique and review of the literature

Enrico Vizza, Emanuela Mancini, Ermelinda Baiocco, Cristina Vicenzoni, Lodovico Patrizi, Maria Saltari, Monica Cimino, Stefano Sindico, Giacomo Corrado

Research output: Contribution to journalArticle

Abstract

Background. Lymph node status is a prognostic factor for gynecologic cancer. We describe a new developing strategy for robotic transperitoneal aortic lymphadenectomy without relocating the robotic column or the patient. Methods. Patients with histologically confirmed cervical cancer, early ovarian cancer, or endometrial carcinoma with suspected risk factors indicating aortic lymphadenectomy were eligible for the robotic transperitoneal aortic lymphadenectomy using the Da Vinci robotic system as part of the surgical treatment of gynecologic malignancies. Results. The mean operating time was 224 min (range 160-300 min), and the mean console time for aortic lymphadenectomy was 43 min (range 30-75). The median hemoglobin fall was 1.3 g/dL range (0.8-2 g/dL), the median number of removed aortic lymph nodes was 12.5 (range 7-17), and the median length of the hospital stay was 2 days (range 1-4 days). We experienced an intraoperative complication, but no conversion to laparotomy was necessary. No patients received a blood transfusion. Conclusions. This initial experience demonstrates the feasibility of robotic aortic lymphadenectomy with good accuracy and safety without relocating the robotic column or the patient.

Original languageEnglish
Pages (from-to)3832-3838
Number of pages7
JournalAnnals of Surgical Oncology
Volume19
Issue number12
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Robotics
Lymph Node Excision
Neoplasms
Length of Stay
Lymph Nodes
Intraoperative Complications
Endometrial Neoplasms
Blood Transfusion
Uterine Cervical Neoplasms
Ovarian Neoplasms
Laparotomy
Hemoglobins
Safety

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Robotic transperitoneal aortic lymphadenectomy in gynecologic cancer : A new robotic surgical technique and review of the literature. / Vizza, Enrico; Mancini, Emanuela; Baiocco, Ermelinda; Vicenzoni, Cristina; Patrizi, Lodovico; Saltari, Maria; Cimino, Monica; Sindico, Stefano; Corrado, Giacomo.

In: Annals of Surgical Oncology, Vol. 19, No. 12, 11.2012, p. 3832-3838.

Research output: Contribution to journalArticle

Vizza, Enrico ; Mancini, Emanuela ; Baiocco, Ermelinda ; Vicenzoni, Cristina ; Patrizi, Lodovico ; Saltari, Maria ; Cimino, Monica ; Sindico, Stefano ; Corrado, Giacomo. / Robotic transperitoneal aortic lymphadenectomy in gynecologic cancer : A new robotic surgical technique and review of the literature. In: Annals of Surgical Oncology. 2012 ; Vol. 19, No. 12. pp. 3832-3838.
@article{387997acd4204cb7b723db1d3fcd1c6f,
title = "Robotic transperitoneal aortic lymphadenectomy in gynecologic cancer: A new robotic surgical technique and review of the literature",
abstract = "Background. Lymph node status is a prognostic factor for gynecologic cancer. We describe a new developing strategy for robotic transperitoneal aortic lymphadenectomy without relocating the robotic column or the patient. Methods. Patients with histologically confirmed cervical cancer, early ovarian cancer, or endometrial carcinoma with suspected risk factors indicating aortic lymphadenectomy were eligible for the robotic transperitoneal aortic lymphadenectomy using the Da Vinci robotic system as part of the surgical treatment of gynecologic malignancies. Results. The mean operating time was 224 min (range 160-300 min), and the mean console time for aortic lymphadenectomy was 43 min (range 30-75). The median hemoglobin fall was 1.3 g/dL range (0.8-2 g/dL), the median number of removed aortic lymph nodes was 12.5 (range 7-17), and the median length of the hospital stay was 2 days (range 1-4 days). We experienced an intraoperative complication, but no conversion to laparotomy was necessary. No patients received a blood transfusion. Conclusions. This initial experience demonstrates the feasibility of robotic aortic lymphadenectomy with good accuracy and safety without relocating the robotic column or the patient.",
author = "Enrico Vizza and Emanuela Mancini and Ermelinda Baiocco and Cristina Vicenzoni and Lodovico Patrizi and Maria Saltari and Monica Cimino and Stefano Sindico and Giacomo Corrado",
year = "2012",
month = "11",
doi = "10.1245/s10434-012-2411-6",
language = "English",
volume = "19",
pages = "3832--3838",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York LLC",
number = "12",

}

TY - JOUR

T1 - Robotic transperitoneal aortic lymphadenectomy in gynecologic cancer

T2 - A new robotic surgical technique and review of the literature

AU - Vizza, Enrico

AU - Mancini, Emanuela

AU - Baiocco, Ermelinda

AU - Vicenzoni, Cristina

AU - Patrizi, Lodovico

AU - Saltari, Maria

AU - Cimino, Monica

AU - Sindico, Stefano

AU - Corrado, Giacomo

PY - 2012/11

Y1 - 2012/11

N2 - Background. Lymph node status is a prognostic factor for gynecologic cancer. We describe a new developing strategy for robotic transperitoneal aortic lymphadenectomy without relocating the robotic column or the patient. Methods. Patients with histologically confirmed cervical cancer, early ovarian cancer, or endometrial carcinoma with suspected risk factors indicating aortic lymphadenectomy were eligible for the robotic transperitoneal aortic lymphadenectomy using the Da Vinci robotic system as part of the surgical treatment of gynecologic malignancies. Results. The mean operating time was 224 min (range 160-300 min), and the mean console time for aortic lymphadenectomy was 43 min (range 30-75). The median hemoglobin fall was 1.3 g/dL range (0.8-2 g/dL), the median number of removed aortic lymph nodes was 12.5 (range 7-17), and the median length of the hospital stay was 2 days (range 1-4 days). We experienced an intraoperative complication, but no conversion to laparotomy was necessary. No patients received a blood transfusion. Conclusions. This initial experience demonstrates the feasibility of robotic aortic lymphadenectomy with good accuracy and safety without relocating the robotic column or the patient.

AB - Background. Lymph node status is a prognostic factor for gynecologic cancer. We describe a new developing strategy for robotic transperitoneal aortic lymphadenectomy without relocating the robotic column or the patient. Methods. Patients with histologically confirmed cervical cancer, early ovarian cancer, or endometrial carcinoma with suspected risk factors indicating aortic lymphadenectomy were eligible for the robotic transperitoneal aortic lymphadenectomy using the Da Vinci robotic system as part of the surgical treatment of gynecologic malignancies. Results. The mean operating time was 224 min (range 160-300 min), and the mean console time for aortic lymphadenectomy was 43 min (range 30-75). The median hemoglobin fall was 1.3 g/dL range (0.8-2 g/dL), the median number of removed aortic lymph nodes was 12.5 (range 7-17), and the median length of the hospital stay was 2 days (range 1-4 days). We experienced an intraoperative complication, but no conversion to laparotomy was necessary. No patients received a blood transfusion. Conclusions. This initial experience demonstrates the feasibility of robotic aortic lymphadenectomy with good accuracy and safety without relocating the robotic column or the patient.

UR - http://www.scopus.com/inward/record.url?scp=84868102383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868102383&partnerID=8YFLogxK

U2 - 10.1245/s10434-012-2411-6

DO - 10.1245/s10434-012-2411-6

M3 - Article

C2 - 22644509

AN - SCOPUS:84868102383

VL - 19

SP - 3832

EP - 3838

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 12

ER -